Morgan Stanley (MS) Stock Analysis - DCF Valuation & AI Disruption Risk

MS — ~$220, 16.3x trailing P/E, after a Q2 2026 print featuring record $6.3B equities trading, $2.44B IB revenue on SpaceX/Cerebras deals, and total client assets crossing $10T with a record $148.1B in net new assets tied to SpaceX IPO inflows.

Quantitative model rating — not individualized investment advice.

How Is This Rating Calculated?

1. Margin of safety → quantitative grade

Blended valuation margin-of-safety bands
Margin of safetyQuant gradeScore
MOS > 20.00%Strong Buy5.0
10.00% < MOS ≤ 20.00%Buy4.0
−10.00% < MOS ≤ 10.00%Hold3.0
−20.00% < MOS ≤ −10.00%Reduce2.0
MOS ≤ −20.00%Avoid1.0

2. Auto fundamental penalty

Automatic fundamental-penalty rules
RuleThresholdPenalty
P/E extremeForward (or trailing) P/E > 80x−1.0
P/E elevatedForward (or trailing) P/E 50–80x−0.5
Earnings deterioration, significantEarnings growth < −20%−1.0
Earnings deterioration, mildEarnings growth −5% to −20%−0.5
Stagnant top-lineRevenue growth < 3%−0.5
Unsustainable dividendPayout ratio > 120%−0.5

3. Thesis conviction modifier

Analyst-conviction modifier scale
Conviction levelModifier
Very High+1.00
High+0.60
Medium+0.00
Low-0.60
Very Low-1.00

4. Composite score → final grade

Composite score → grade thresholds
Composite score rangeGrade
Score ≥ 4.50Strong Buy
3.50 ≤ Score < 4.50Buy
2.50 ≤ Score < 3.50Hold
1.50 ≤ Score < 2.50Reduce
Score < 1.50Avoid
MS Price Target & Rating

MS's quantitative grade is Hold, with moderate downside risk (CVaR -11.5%), and quality metrics (net margin 26%, ROE 18%). Morgan Stanley (MS) trades at $216.33 with a Hold composite rating: a trailing P/E of 17.3x at a 23% premium to sector median, net margins of 25.9%, a blended fair-value range of $174–$259 suggesting a +4% margin of safety, beta 1.21 (moderate risk profile).

MS's blended fair-value range is $174–$259 (base case $225), against a current price of $216.33.

VALUEFAIR RANGEPREMIUM BEAR$174.33BULL$258.74 BASE$225 CURRENT$216 UPSIDE TO BASE+4.1% DCF VALUATION RANGE · MS
MS blended fair-value gauge — bear case $174, base case $225, bull case $259, current price $216.33.
Price & DCF data as of

Drag to simulate MS's price moving between the blended bear ($174) and bull ($259) fair-value anchors — left for a price fall, right for a rise — and see how the margin of safety vs A.L. Capital Advisory's $225 blended base-case fair value changes. Starting point: the page's as-of price of $216.33 on 2026-08-08.

DCF Assumptions
DCF assumptions by scenario
InputBearBaseBull
Stage-1 (near-term) growth3.60%8.00%12.00%
Terminal growth2.00%2.00%2.00%
CAPM cost of equity (discount rate)12.21%11.31%10.41%
Forecast horizon5 years5 years5 years
DCF-to-intrinsic-value blend by scenario
ScenarioPure DCF valueAnalyst target usedBlended intrinsic value (displayed)
Bear$145.31$184.00$174.33
Base$190.79$236.62$225.16
Bull$248.96$262.00$258.74
Analyst-coverage-to-consensus-weight tiers
Analyst coverageWeight
0–1 analysts0.00% consensus / 100.00% DCF
2–4 analysts40.00% consensus / 60.00% DCF
5–19 analysts65.00% consensus / 35.00% DCF
20+ analysts75.00% consensus / 25.00% DCF
  • Valuation: Hold grade — P/E 17.3x — blended fair-value range $174–$259 implies +4% margin of safety
  • Risk: CVaR -11.5% (95th percentile, 1-month) indicates moderate tail exposure; beta of 1.21 amplifies broad market moves in both directions
  • Strengths: Quality 4.0/5, Size 4.5/5, 26% net margin, 18% ROE dominate the factor profile
  • Catalyst: Q3 2026 earnings (mid-October 2026) — durability check on record equities trading, IB deal pipeline beyond SpaceX/Cerebras, and net-new-asset pace after the $148.1B SpaceX-linked quarter.
  • Bear catalyst: Net new asset growth decelerates sharply below historical run-rate; equities/IB revenue reverts hard off the record quarter; insider selling accelerates alongside continued multiple expansion.
MS — Quantitative Snapshot August 2026
RatingHold
Price$216.33
Why HoldHigh-quality business at a fully-priced valuation — limited margin for error on earnings
Main riskValue score 2.5/5 signals premium pricing relative to peers
Tail riskCVaR -11.5% over one month at the 95th percentile
Blended fair-value range$174–$259 blended fair-value range; margin of safety +4%
Best useCore large-cap Financials holding — not a source of diversified sector exposure
Next watchEarnings delivery consistency and margin trajectory

MS's composite five-factor score is 3.3/5, led by Size (4.5/5) and weakest on Value (2.5/5).

MS Quantitative Factor Radar Chart Pentagon radar chart showing MS factor scores: Value 2.5, Quality 4.0, Momentum 3.0, Volatility 2.5, Size 4.5 — each scored on a 1 to 5 scale. VALUE 2.5 QUALITY 4.0 MOMENTUM 3.0 VOLATILITY 2.5 SIZE 4.5
MS five-factor radar — Value 2.5, Quality 4.0, Momentum 3.0, Volatility 2.5, Size 4.5 (out of 5).
Value
2.5 / 5
Quality
4.0 / 5
Momentum
3.0 / 5
Volatility
2.5 / 5
Size
4.5 / 5
MS Five-Factor Quantitative Scores
FactorScore
Value2.5 / 5
Quality4.0 / 5
Momentum3.0 / 5
Volatility2.5 / 5
Size4.5 / 5
AI Disruption Risk: Moderate

Morgan Stanley's AI durability case rests on internal productivity tooling with unusually concrete adoption data: AI @ Morgan Stanley Debrief and the AI @ Morgan Stanley Assistant reached 98% adoption among wealth-management financial advisors and are accessible to nearly half of total headcount, while AskResearchGPT extends the same generative-AI stack into institutional research synthesis. That adoption breadth is a genuine efficiency driver in the highest-margin part of the franchise, converting meeting notes and CRM updates into automated workflows rather than billable advisor time. The disruption risk is less about AI-native fintech undercutting advisory fees today and more about whether high adoption numbers translate into disclosed headcount or margin outcomes -- the company has not published headcount-reduction figures tied to Debrief the way JPMorgan has for its own tools. Investors should watch wealth-management pretax margin trends and any disclosed advisor-productivity metrics.

MS Key Metrics — Morgan Stanley 2026
MetricValue
Current Price$216.33
P/E Ratio (TTM)17.3x
Forward P/E15.9x
PEG Ratio0.25x
P/S Ratio4.4
Beta1.21
Net Margin25.9%
ROE18.0%
Debt/Equity517.3%
Dividend Yield2.15%
CVaR (95%, 1M)-11.5%
Market Cap$340.1B
1-Month CVaR Methodology
  • Lookback: most recent 1 year of daily prices.
  • Return input: daily log returns on dividend/split-adjusted close prices.
  • Horizon construction: rolling, overlapping 21-trading-day (~1 calendar month) sums of daily log returns.
  • Confidence level: 95% (worst 5% of the resulting rolling-month observations).
  • Quantile convention: floor-based cutoff — the worst floor(N × 0.05) rolling-month observations (minimum 1), not a rounded or interpolated percentile.
  • CVaR: arithmetic mean of that worst-5% tail, expressed as a percentage.
  • Corporate actions: reflected via adjusted-close pricing (dividends and splits are accounted for).
1M CVaR-95 by lookback window
Method1M CVaR-95
Trailing 1-year historical-11.5%
Trailing 3-year historical-14.9%
Trailing 5-year historical-15.8%
Historical Simulation · Daily Log Returns
MS — Daily Return Distribution
Morgan Stanley  ·  250 trading days  ·  CVaR illustrated on real data
Aug 2025 – Aug 2026 Daily log returns
95%
-2.77%
1-Day VaR · 95%
95th-percentile loss threshold
-3.98%
1-Day CVaR · 95%
Avg loss in tail
13
Days in tail
of 250 sessions
250
Daily returns
Aug 2025 – Aug 2026
ℹ️
Risk Framework · A.L. Capital Advisory
CVaR & Tail-Risk Methodology
Why variance understates downside risk in non-normal distributions — and how CVaR corrects that blind spot
Analyst View
Anton Ladnyi, CFA · A.L. Capital Advisory Updated 2026-08-08

MS — ~$220, 16.3x trailing P/E, after a Q2 2026 print featuring record $6.3B equities trading, $2.44B IB revenue on SpaceX/Cerebras deals, and total client assets crossing $10T with a record $148.1B in net new assets tied to SpaceX IPO inflows.

↑ Bull Case
  • $10 trillion total client assets milestone crossed in Q2 2026, cementing MS's position as the largest wealth/investment-management platform among the major banks.
  • $148.1B in record net new assets in the quarter, driven by SpaceX IPO-related inflows, shows the wealth-management flywheel is compounding beyond trading.
  • $6.3B in record equities trading revenue plus $2.44B in IB revenue (SpaceX, Cerebras deals) show capital-markets strength complementing the wealth business.
  • 25 analysts carry a consensus Buy rating (S&P Global poll), with several July 2026 target raises (Evercore to $233, BofA to $250) following the print.
↓ Bear Case
  • $151.11 GF Value estimate versus the ~$213-220 trading price implies ~42% overvaluation on that model, a meaningfully bigger gap than peers.
  • $17.7M in insider share sales over the trailing three months is a soft signal worth monitoring alongside the stock's proximity to highs.
  • $190 consensus price target from one major poll (Benzinga, 23 analysts) sits below the current price, underscoring real disagreement on further upside from here.
  • $148.1B net-new-asset record is partly a one-time SpaceX-IPO-linked inflow; the growth rate is unlikely to repeat at the same magnitude next quarter.
Catalyst: Net new assets sustain a high run-rate even below the $148.1B SpaceX-linked peak; equities trading revenue holds near record levels; IB deal pipeline shows depth beyond the one-off SpaceX/Cerebras wins.
Model downgrade conditions: Net new asset growth decelerates sharply below historical run-rate; equities/IB revenue reverts hard off the record quarter; insider selling accelerates alongside continued multiple expansion.
Hold means what it says here — I am not selling, but I am not buying either. The risk/reward at current prices is roughly balanced, and roughly balanced is not enough reason to deploy fresh capital. The DCF sits close to the current price — no compelling discount, no obvious overshoot. In that setup, everything rides on the next earnings report. That is the moment I am watching: whether the delivery justifies the multiple, or whether the stock needs to come in before the risk/reward works again. Re-accelerating earnings surprise magnitude would shift my view constructive. Continued compression of beat magnitude at this multiple would move me toward a reduce.
— Anton Ladnyi, CFA
MS Earnings History — EPS Surprise Rate 2026
QuarterEPS Est. (consensus)EPS Actual (adjusted, consensus basis)Surprise
Q2 2026$2.93$3.46+17.9%
Q1 2026$3.02$3.43+13.7%
Q4 2025$2.45$2.68+9.4%
Q3 2025$2.11$2.80+32.6%

MS has beaten consensus EPS estimates in 4 of the last 4 reported quarters (100%).

$0.00$1.00$2.00$3.00$4.00 +32.6%+9.4%+13.7%+17.9% Q3'25Q4'25Q1'26Q2'26 BEAT RATE4/4 ESTIMATEBEATMISS EPS ACTUAL vs ESTIMATE · MS
MS quarterly EPS — estimate vs. actual, 4 most recent reported quarters, 100% beat rate.
MS Forward EPS Consensus Estimates 2026
QuarterEPS Est.YoY EPSAnalysts
Q3 2026$3.16+12.9%14
Q4 2026$2.94+9.8%14
Q1 2027~$3.41-0.6%21
Q2 2027~$3.41-1.5%21
~ Estimated from annual consensus — not a direct analyst survey

Wall Street's next-quarter consensus EPS estimate for MS is $3.16.

$0.00$1.00$2.00$3.00$4.00$5.00 +13%+10%-1%-1% Q3 2026Q4 2026Q1 2027Q2 2027 ESTIMATE TRENDMODEL-IMPLIED ACCELERATING CONSENSUS EPSANALYST RANGEBased on 14–21 analyst estimates per quarter — dashed bars are model-allocated from annual consensus, not direct quarterly surveys EPS FORWARD ESTIMATES · MS
MS consensus EPS estimates, next quarter $3.16, 4 quarters shown.
MS Peer Valuation Comparison 2026
TickerP/E (TTM)Fwd P/EBeta1M CVaR-95Net Margin
MS17.3x15.9x1.21-11.5%25.9%
GS15.9x14.0x1.29-13.3%31.0%
JPM15.3x14.3x0.98-9.1%34.9%
BRK-B15.6x24.2x0.61-5.2%19.3%
V30.9x24.2x0.76-7.8%50.8%
Revenue growth × exit multiple (editorial, not mechanically reproducible from disclosed inputs) · hover each scenario for detail · current price $216.33
BEAR$155BASE$240BULL$290 $216 ANALYST SCENARIO RANGE · MS
Bear Case
$155
-28.4%
Implied NTM P/E: 12.0x (target ÷ next-4Q consensus EPS — distinct from the exit multiple below, which is applied to a later-year EPS estimate)
5% revenue CAGR · 12x exit multiple
Base Case
$240
+10.9%
Implied NTM P/E: 18.6x (target ÷ next-4Q consensus EPS — distinct from the exit multiple below, which is applied to a later-year EPS estimate)
12% revenue CAGR · 16x exit multiple
Bull Case
$290
+34.1%
Implied NTM P/E: 22.4x (target ÷ next-4Q consensus EPS — distinct from the exit multiple below, which is applied to a later-year EPS estimate)
18% revenue CAGR · 19x exit multiple

3 of 10 peer pairs correlated above 0.60, indicating meaningful historical diversification across the selected names, although all remain exposed to common equity, sector and macro factors.

Pairwise Correlation Matrix — MS vs GS vs JPM vs V vs BRK-B 5×5 pairwise correlation matrix showing co-movement between MS, GS, JPM, V, BRK-B over a trailing 12-month window. MS GS JPM V BRK-B MS GS JPM V BRK-B 1.00 0.85 0.65 0.11 0.01 0.85 1.00 0.65 0.10 -0.02 0.65 0.65 1.00 0.31 0.27 0.11 0.10 0.31 1.00 0.36 0.01 -0.02 0.27 0.36 1.00
MS pairwise correlation heatmap across 5 peers — 3 of 10 pairs above 0.60.
3 of 10 peer pairs correlated above 0.60, indicating meaningful historical diversification across the selected names, although all remain exposed to common equity, sector and macro factors.
Extended Analysis — Buy, Hold or Sell? Risk Factors. Portfolio Fit.

Is MS a buy, hold, or sell?

MS carries a quantitative grade of Hold. The trailing P/E of 17.3 sits 23% above the Financials sector median of 14.0x — a premium that demands sustained earnings delivery. Our two-stage, EPS-based DCF model produces a pure model range of $145–$249. After blending with Street consensus targets, the displayed fair-value range is $174–$259 — implying a +4% margin of safety vs. blended base fair value at the current price of $216.33. The width of the range reflects genuine uncertainty in the terminal growth rate assumption: the correct framework is a probability-weighted distribution over scenarios, not a single point estimate. See the DCF valuation framework for full methodology.

MS has beaten consensus estimates in 100% of the last 4 reported quarters, signalling strong execution consistency. The most recent quarter delivered a 17.9% earnings surprise. Analyst estimate revisions are trending flat.

What are MS's key risk factors?

With a beta of 1.21, MS exhibits an above-market risk profile relative to the broad market. The 95th-percentile CVaR of -11.5% on a one-month horizon should inform position sizing directly: at a 10% portfolio weight, this standalone tail outcome corresponds to approximately 1.2% of portfolio value before accounting for correlations with other holdings — not a marginal portfolio CVaR contribution, which depends on the full covariance structure. Net margins stand at 25.9%. Return on equity of 18.0% suggests solid capital efficiency. Debt-to-equity of 517% warrants monitoring for leverage risk.

The options market shows a put/call ratio of 1.67, reflecting a notably bearish skew in derivative positioning. Implied and realized volatility are roughly aligned at 32.4% and 33.6% respectively. Insiders have been net sellers to the tune of $121.7M over the disclosed transactions from 2024-10-17 to 2026-07-28. While routine dispositions are common, the magnitude bears watching.

How does MS fit in a diversified portfolio?

At typical HENRY portfolio weights — 10–20% of the equity allocation — MS carries a beta of 1.21, meaning it amplifies broad market moves proportionally. The appropriate weight is not a function of conviction alone, but of the full covariance structure across all holdings. See the Ledoit-Wolf covariance framework for the methodology behind these calculations.

Among closely correlated names, MS shows the strongest co-movement with GS (0.85), JPM (0.65), V (0.11). Investors seeking diversification should note these correlation dynamics when constructing multi-asset portfolios. With the top peer correlation at 0.85, adding MS to a portfolio that already holds these names provides limited marginal diversification benefit — particularly during stress events when correlations converge toward 1.0.

True portfolio risk is a function of the full covariance structure across all holdings — not individual stock metrics. The Portfolio Health Check quantifies this at the portfolio level: it surfaces hidden concentration, marginal CVaR contributions, and the degree to which your overall allocation deviates from an optimal risk-adjusted mandate. The MS analysis here is a single node in that larger structure.

What is MS's AI-Era Durability & Disruption Risk Score?

Morgan Stanley's AI durability case rests on internal productivity tooling with unusually concrete adoption data: AI @ Morgan Stanley Debrief and the AI @ Morgan Stanley Assistant reached 98% adoption among wealth-management financial advisors and are accessible to nearly half of total headcount, while AskResearchGPT extends the same generative-AI stack into institutional research synthesis. That adoption breadth is a genuine efficiency driver in the highest-margin part of the franchise, converting meeting notes and CRM updates into automated workflows rather than billable advisor time. The disruption risk is less about AI-native fintech undercutting advisory fees today and more about whether high adoption numbers translate into disclosed headcount or margin outcomes -- the company has not published headcount-reduction figures tied to Debrief the way JPMorgan has for its own tools. Investors should watch wealth-management pretax margin trends and any disclosed advisor-productivity metrics.

What is MS's intrinsic value and DCF price target?

A.L. Capital Advisory's model produces a blended fair-value range (25% pure DCF, 75% analyst consensus for well-covered names) of $174 (bear case) to $259 (bull case) for Morgan Stanley (MS). At $216.33, the margin of safety vs. blended base case is +4% (positive = discount to fair value; negative = premium). The bear-to-bull spread reflects genuine sensitivity to the two dominant DCF inputs: the terminal growth rate and the CAPM cost of equity (this model discounts EPS, an equity-level metric, so the cost of equity rather than a debt-weighted WACC is the applicable discount rate). Terminal value typically accounts for 60-80% of total intrinsic value in most equity DCF models, which is why a range is more analytically sound than a point estimate. The central analytical question is not what the DCF outputs as a single number but which growth trajectory the current market price already discounts. All DCF analysis follows CFA Institute standards and is conducted by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: DCF Valuation Framework →

Is MS a buy or sell in 2026?

Morgan Stanley (MS) carries a Hold quantitative rating from A.L. Capital Advisory, set by Discounted Cash Flow margin-of-safety band with no analyst-conviction overlay applied. Five-factor model scoring (Value, Quality, Momentum, Volatility, Size) and CVaR tail risk measurement are shown separately on the page. At $216.33, the margin of safety vs. blended base fair value is +4% (blended fair-value range: $174 bear – $259 bull). That places the current price in the Fair Range zone of A.L. Capital Advisory's DCF framework, which sets the quantitative grade component that determines this rating. Composite factor score: 3.3/5. Strongest factor: Size (4.5/5). Weakest factor: Value (2.5/5). Trailing P/E: 17.3x. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Rating Methodology (this page) →

What is the average analyst target price for MS?

Wall Street consensus target for MS: $236.62 (+9.4% upside from the current price of $216.33). The analyst target range spans $184.00 (most bearish) to $262.00 (most bullish). Consensus recommendation: Buy. Note that analyst price targets typically reflect a 12-month forward horizon and are derived from a blend of DCF, comparable-company, and sum-of-the-parts analysis. A.L. Capital Advisory's Hold composite rating is calculated from the blended margin-of-safety grade, applicable automatic fundamental penalties, and a disclosed qualitative analyst-conviction overlay — not from five-factor scores or CVaR, which are supporting diagnostics shown elsewhere on this page. The displayed blended fair value combines the standalone DCF output with Street consensus for well-covered names (see the DCF Assumptions box for the exact blend weight), so it does not track Street consensus mechanically, but it is not fully independent of it either. When the composite rating and the Street consensus recommendation diverge, the divergence itself is informative: it can reflect differences in time horizon, valuation methodology, or the degree to which the current price already discounts the consensus case. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Data & Sources (this page) →

How does MS score on Value, Quality, Momentum, Volatility, and Size?

MS five-factor scores (A.L. Capital Advisory, 1–5 scale): Value 2.5/5 (neutral) — measures the trailing P/E multiple versus the sector median (not the DCF or blended fair-value range, which are separate metrics on this page); Quality 4.0/5 (above average) — captures profitability metrics including return on equity (ROE: 18.0%) and net margin (25.9%) — sustained above-peer ROE and margins are the model's proxy for economic moat and pricing power; Momentum 3.0/5 (neutral) — reflects recent price trajectory and earnings surprise consistency; Volatility 2.5/5 (neutral) — inverse measure derived from beta, where lower historical volatility earns a higher score; Size 4.5/5 (strong) — market capitalisation rank (mega-cap $1T+ scores 5/5). Composite: 3.3/5. Factor scores above 4.0 signal a tailwind in that dimension; below 2.0 signals a material headwind. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory.

What is MS's tail risk and CVaR?

The 95th-percentile Conditional Value at Risk (CVaR) for MS on a one-month horizon is -11.5%. CVaR represents the expected average loss in the worst 5% of monthly outcomes — a more conservative tail risk measure than standard VaR, which only marks the loss threshold. Beta of 1.21 indicates above-market systematic sensitivity with amplified drawdown exposure — beta measures historical sensitivity to market moves, not total volatility. For reference, a diversified S&P 500 ETF carries a one-month CVaR of roughly -8% to -12% in normal market conditions; individual equity CVaR is higher due to idiosyncratic risk. At the portfolio level, what matters is the marginal CVaR contribution of each holding — not its standalone figure. The A.L. Capital Advisory Portfolio Health Check quantifies each position's marginal tail-risk contribution across your entire holdings. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: CVaR & Tail-Risk Methodology →

What would trigger a rating upgrade or downgrade for MS?

Upgrade trigger: A price pullback that opens the margin of safety beyond +15% (approximately $148 based on the DCF bear case). Downgrade trigger: a sustained reversal in the Quality and Momentum factor scores for two or more consecutive quarters. These triggers are reassessed each time the underlying fundamentals, price, or earnings data refresh — the current Hold rating is not held on a fixed review calendar. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Rating Methodology (this page) →

Does MS consistently beat earnings estimates?

MS has beaten consensus EPS estimates in 4 of the 4 most recently reported quarters (100%) — indicating consistent delivery across the latest 4 reported quarters. The most recent reported quarter beat consensus by 17.9%. Sustained above-consensus delivery supports both the Momentum and Quality factor scores and provides a tailwind to the current rating. Across the 4 most recently reported quarters with valid consensus data, a beat rate above 70% signals consistent execution in this model, while a rate below 50% typically corresponds to a Momentum factor score of 3.0/5 or below. Earnings surprise magnitude and direction are incorporated into the Momentum and Quality dimensions of the five-factor scoring model. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Earnings History (this page) →

How does MS contribute to portfolio risk and diversification?

MS carries a beta of 1.21 (high-volatility / growth-sensitive relative to the broad equity market). A beta above 1.0 means the position amplifies market moves in both directions at a typical portfolio weight. Strongest peer co-movement: GS (0.85), JPM (0.65), V (0.11). Holding MS alongside these names in the same portfolio increases concentration risk. True portfolio risk is a function of the full covariance structure — a single stock's beta does not reveal its marginal contribution to portfolio tail loss. The A.L. Capital Advisory Portfolio Health Check quantifies concentration risk (Herfindahl-Hirschman Index), pairwise correlations, and marginal CVaR contribution across all your holdings. If a single position such as this one makes up an outsized share of your net worth — employer stock, RSUs, or concentrated equity compensation — a Strategic Session builds the sequencing plan and the written allocation that follows from it. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Ledoit-Wolf Covariance Framework →

What quantitative methodology does A.L. Capital Advisory use to analyse MS?

A.L. Capital Advisory analyses Morgan Stanley (MS) using a four-part quantitative research framework grounded in CFA Institute standards (not all four parts feed the composite rating formula directly — see below). (1) DCF Valuation: a two-stage earnings-based DCF that projects EPS (not free cash flow) under bear and bull assumptions, discounts at the CAPM cost of equity (the applicable rate for an equity-level metric like EPS, not a debt-weighted WACC) to produce an intrinsic value range with margin-of-safety calculation. (2) Five-Factor Scoring: each equity is scored 1–5 on Value, Quality, Momentum, Volatility, and Size. (3) CVaR Tail Risk: 95th-percentile Conditional Value at Risk from historical simulation of daily returns on a one-month horizon. (4) Earnings Surprise Analysis: quarterly beat rate and magnitude, shown for context alongside the factor scores. The current Hold composite rating for MS is calculated separately from this broader framework: it consists of a Hold quantitative grade, any automatic fundamental penalty, and a disclosed qualitative analyst-conviction overlay — see this page's Rating Methodology section for the exact formula. Five-factor scoring, CVaR and earnings surprise analysis below are supporting research diagnostics shown separately on this page; they are not direct numerical inputs into this specific composite-rating calculation. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: DCF Valuation Framework →  ·  CVaR & Tail-Risk Methodology →

Stress-Test This View Live

Run MS in Asset Lens

Live DCF valuation, Monte Carlo simulation, options flow intelligence, and full factor decomposition — updated in real time. Free, no account required.

Launch Live Analysis →
Anton Ladnyi — Founder & Portfolio Architect, A.L. Capital Advisory, ex-Goldman Sachs, CFA
Anton Ladnyi, CFA
Founder & Portfolio Architect — A.L. Capital Advisory
Ex-Goldman Sachs Equity Research · Ex-J.P. Morgan Wealth Management · CFA Charterholder
Data & Sources
MS data sources and as-of dates
MetricSourceObservation basis
[1] Company financials & management guidanceSEC EDGAR filings (all forms — 10-K, 10-Q, 8-K earnings releases) →Most recent reported quarter: 2026-06-30
[2] Market priceYahoo Finance quote →2026-08-08T09:59:19+00:00 (UTC) · Market closed (weekend)
[3] Consensus EPS & analyst price targetsYahoo Finance analyst estimates →Retrieved 2026-08-08T09:59:19+00:00 (UTC); see per-quarter analyst counts in Earnings Forecast; individual target ages/dates are not disclosed by the data provider
[4] Insider transactionsYahoo Finance insider transactions →Disclosed transaction dates shown inline where cited (SEC Form 4 basis)
[5] Short interestYahoo Finance key statistics →Most recent exchange settlement date on file with the data provider (exact settlement date not exposed by the provider's API; retrieved 2026-08-08T09:59:19+00:00 UTC)
[6] DCF valuation, five-factor model & composite ratingA.L. Capital Advisory proprietary model →Calculated 2026-08-08T09:59:19+00:00 (UTC); see Rating Methodology above for the exact formula
Legal Disclaimer & Important Notices

This analysis is produced using a systematic quantitative framework applied to market data and does not constitute investment advice. Prose commentary is AI-assisted and generated from structured quantitative inputs. All data and metrics are as of 2026-08-08 and are point-in-time estimates subject to revision without notice. CVaR figures are based on historical simulation and do not guarantee future outcomes. DCF ranges and upgrade/downgrade triggers are forward-looking statements based on current assumptions and may not materialise. Past performance does not guarantee future results. This analysis does not account for individual circumstances, tax position, or investment objectives — consult a qualified financial advisor before making investment decisions. This content is intended for informational purposes only and does not constitute regulated investment advice under MiFID II or FCA guidelines. This content is not intended for US persons or residents of jurisdictions where its distribution would be contrary to local law or regulation. This service is not directed at residents of Finland, Sweden, Norway, Denmark, Iceland, or Poland. The author may hold long or short positions in securities mentioned in this analysis. Nothing on this page represents a solicitation to buy or sell any security. A.L. Capital Advisory is an independent private advisory practice and is not affiliated with Morgan Stanley.

CFA Portfolio Advisory — MS Discuss this analysis, position sizing, or your full portfolio mandate with Anton Ladnyi, CFA.